Comment on

• Inverse relation between prostate-specific antigen and insulin-like growth factor-binding protein 3 in bone metastases and serum of patients with prostate cancer.

  Smith GL, Doherty AP, Mitchell H, Hanham IW, Christmas TJ, Epstein RJ. Smith GL, et al. Lancet. 1999 Dec 11;354(9195):2053-4. doi: 10.1016/S0140-6736(99)04805-9. Lancet. 1999. PMID: 10636379
• Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening?

  Wolk A, Andersson SO, Mantzoros CS, Trichopoulos D, Adami HO. Wolk A, et al. Lancet. 2000 Dec 2;356(9245):1902-3. doi: 10.1016/S0140-6736(00)03266-9. Lancet. 2000. PMID: 11130391